Stockscreener 앱 받기
7.99
0.50%
0.04
시간 외 거래:
7.99
전일 마감가:
$7.95
열려 있는:
$7.84
하루 거래량:
12,826
Relative Volume:
0.08
시가총액:
$4.25M
수익:
-
순이익/손실:
$-5.00M
주가수익비율:
-0.0279
EPS:
-286.8504
순현금흐름:
$-4.43M
1주 성능:
+6.68%
1개월 성능:
-16.60%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$7.70
$8.00
1주일 범위
$7.4283
$8.3899
52주 변동 폭
$6.3829
$16.92
Decoy Therapeutics Inc Stock (DCOY) Company Profile
명칭
Decoy Therapeutics Inc
전화
346-772-0346
주소
2450 HOLCOMBE BLVD, HOUSTON
Compare DCOY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCOY
Decoy Therapeutics Inc
|
7.99 | 4.23M | 0 | -5.00M | -4.43M | -286.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Decoy Therapeutics Inc Stock (DCOY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-23 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-27 | 개시 | Ladenburg Thalmann | Buy |
Decoy Therapeutics Inc 주식(DCOY)의 최신 뉴스
Decoy Therapeutics partners with Quantori on AI peptide platform By Investing.com - Investing.com Nigeria
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - Lelezard
Decoy Therapeutics Inc. Earnings and Revenue – GETTEX:FP11 - TradingView
Debt to equity ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBIT per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Price to cash flow ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Free cash flow per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Revenue per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net current asset value per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Enterprise value to EBITDA ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Non-controlling/minority interest of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Price to book ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total operating expenses of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
CapEx per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Equity in earnings of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBIT of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total debt per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Debt to assets ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total common shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Operating income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Enterprise value of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBITDA margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Discontinued operations of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics Inc. Statistics – GETTEX:FP11 - TradingView
Gross profit of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Taxes of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Preferred dividends of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Diluted shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
After tax other income/expense of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Diluted net income available to common stockholders of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Pretax income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Non-operating income (total) of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBITDA of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Free float of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics Inc. Revenue Breakdown – GETTEX:FP11 - TradingView
Number of employees of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics (DCOY) Partners with Quantori to Enhance Anti - GuruFocus
Decoy Therapeutics partners with Quantori on AI peptide platform - Investing.com
Decoy Therapeutics enters collaboration with Quantori - TipRanks
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform – NEWSnet Michigan - michigan.newsnetmedia.com
Google Cloud-funded AI aims up to 100-fold faster antiviral peptide design - Stock Titan
Decoy Therapeutics Inc. Revenue Breakdown – MUN:FP11 - TradingView
Decoy Therapeutics Inc. Earnings and Revenue – MUN:FP11 - TradingView
Free cash flow of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total equity of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total assets of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total liabilities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash from financing activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash from operating activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Decoy Therapeutics Inc (DCOY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):